| The intriguing history of cancer immunotherapy P Dobosz, T Dzieciątkowski Frontiers in immunology 10, 2965, 2019 | 421 | 2019 |
| Challenges of the immunotherapy: perspectives and limitations of the immune checkpoint inhibitor treatment P Dobosz, M Stępień, A Golke, T Dzieciątkowski International journal of molecular sciences 23 (5), 2847, 2022 | 30 | 2022 |
| A second update on mapping the human genetic architecture of COVID-19 M Kanai, SJ Andrews, M Cordioli, C Stevens, BM Neale, M Daly, A Ganna, ... Nature 621 (7977), E7-E26, 2023 | 21 | 2023 |
| The Thousand Polish Genomes—a database of Polish variant allele frequencies E Kaja, A Lejman, D Sielski, M Sypniewski, T Gambin, M Dawidziuk, ... International Journal of Molecular Sciences 23 (9), 4532, 2022 | 21 | 2022 |
| TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma J Roszik, E Markovits, P Dobosz, A Layani, K Slabodnik-Kaner, ... Cancer Immunology, Immunotherapy 68, 1493-1500, 2019 | 20 | 2019 |
| Checkpoint genes at the cancer side of the immunological synapse in bladder cancer P Dobosz, PA Stempor, J Roszik, A Herman, A Layani, R Berger, D Avni, ... Translational oncology 13 (2), 193-200, 2020 | 19 | 2020 |
| The intriguing history of cancer immunotherapy. Front Immunol 10: 2965 P Dobosz, T Dzieciątkowski | 13 | 2019 |
| Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (n= 355,591) and randomized … M Banach, N Shekoohi, DP Mikhailidis, GYH Lip, AV Hernandez, ... Archives of Medical Science: AMS 18 (4), 912, 2022 | 12 | 2022 |
| The intriguing history of cancer immunotherapy. Front Immunol. 2019; 10: 2965 P Dobosz, T Dzieciątkowski | 12 | 2019 |
| Genetics, genomics and emerging molecular therapies of pancreatic cancer J Liu, M Mroczek, A Mach, M Stępień, A Aplas, B Pronobis-Szczylik, ... Cancers 15 (3), 779, 2023 | 10 | 2023 |
| Better safe than sorry—Whole-genome sequencing indicates that missense variants are significant in susceptibility to COVID-19 D Słomian, J Szyda, P Dobosz, J Stojak, A Michalska-Foryszewska, ... PLoS One 18 (1), e0279356, 2023 | 7 | 2023 |
| CAPN3 c.1746‐20C>G variant is hypomorphic for LGMD R1 calpain 3‐related M Mroczek, I Inashkina, J Stavusis, P Zayakin, A Khrunin, I Micule, ... Human mutation 43 (10), 1347-1353, 2022 | 7 | 2022 |
| New frontiers in melanoma epigenetics—the more we know, the more we don’t know M Nguyen, P Dobosz Epigenomes 1 (1), 3, 2017 | 7 | 2017 |
| Transcriptional and post-transcriptional regulation of checkpoint genes on the tumour side of the immunological synapse P Dobosz, PA Stempor, M Ramírez Moreno, NA Bulgakova Heredity 129 (1), 64-74, 2022 | 4 | 2022 |
| Beyond GWAS—Could Genetic Differentiation within the Allograft Rejection Pathway Shape Natural Immunity to COVID-19? J Szyda, P Dobosz, J Stojak, M Sypniewski, T Suchocki, K Kotlarz, ... International Journal of Molecular Sciences 23 (11), 6272, 2022 | 4 | 2022 |
| Dziecia tkowski T P Dobosz The intriguing history of cancer immunotherapy. Front Immunol 10, 2965, 2019 | 4 | 2019 |
| Seksualność tancerzy i osób uprawiających japońskie sztuki walki P Dobosz, M Guszkowska Journal of Sexual and Mental Health 11 (1), 2013 | 4 | 2013 |
| WGS data collections: how do genomic databases transform medicine? ZJ Król, P Dobosz, A Ślubowska, M Mroczek International Journal of Molecular Sciences 24 (3), 3031, 2023 | 3 | 2023 |
| SARS-CoV-2 infection activating a novel variant of the NOTCH3 gene and subsequently causing development of CADASIL ZJ Król, M Dorobek, M Dąbrowski, J Zielińska-Turek, B Mruk, J Walecki, ... Archives of Medical Science: AMS 19 (6), 1781, 2023 | 3 | 2023 |
| Comprehensive analysis of correlations in the expression of miRNA genes and immune checkpoint genes in bladder cancer cells PA Stempor, D Avni, R Leibowitz, Y Sidi, M Stępień, T Dzieciątkowski, ... International Journal of Molecular Sciences 22 (5), 2553, 2021 | 3 | 2021 |
